Lexicon Pharmaceuticals reported $-23271000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbott ABT:US $ 2985M 750M
Acadia Pharmaceuticals ACAD:US $ -112.5M 68.38M
Acorda Therapeutics ACOR:US $ -6.2M 1.23M
Agios Pharmaceuticals AGIO:US $ -95.35M 3.32M
Alnylam Pharmaceuticals ALNY:US $ -181.59M 44.32M
AstraZeneca AZN:LN 3562M 625M
Biomarin Pharmaceutical BMRN:US $ 64.42M 7.75M
Bluebird Bio BLUE:US $ -99.42M 19.92M
Clovis Oncology CLVS:US $ -48.44M 2.28M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
Esperion Therapeutics ESPR:US $ -52226000 9.39M
Halozyme Therapeutics HALO:US $ 76.45M 19.11M
Illumina ILMN:US $ 275M 145M
Insmed INSM:US $ -98081000 92K
Intercept Pharmaceuticals ICPT:US $ -10.87M 0.98M
Ironwood Pharmaceuticals IRWD:US $ 56.02M 2.19M
Johnson & Johnson JNJ:US $ 8036M 1273M
Macrogenics MGNX:US $ -63725000 8.44M
Mannkind MNKD:US $ -21.92M 2.4M
Moderna Inc MRNA:US 2.52B 1.78B
Novartis NOVN:VX SF 4660M 108M
Ptc Therapeutics PTCT:US $ -63.18M 2.97M
Puma Biotechnology PBYI:US $ 14.28M 12.77M
Regulus Therapeutics RGLS:US $ -6.54M 0.28M
Sarepta Therapeutics SRPT:US $ -201.24M 125.08M
Thermo Fisher Scientific TMO:US $ 2861M 821M
Ultragenyx Pharmaceutical RARE:US $ -137.11M 4.57M
United Therapeutics UTHR:US $ 214.5M 86M